Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.695 AUD | +2.21% | -0.71% | -22.78% |
Sales 2022 | 1.54M 998K | Sales 2023 | 301K 195K | Capitalization | 17.13M 11.1M |
---|---|---|---|---|---|
Net income 2022 | -11M -7.12M | Net income 2023 | -5M -3.24M | EV / Sales 2022 | 4.57 x |
Net cash position 2022 | 2.25M 1.45M | Net Debt 2023 | 292K 189K | EV / Sales 2023 | 57.9 x |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-2.73
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.29% |
Latest transcript on Zelira Therapeutics Limited
1 day | +2.21% | ||
1 week | -0.71% | ||
Current month | -0.71% | ||
1 month | +1.46% | ||
3 months | -19.65% | ||
6 months | -23.63% | ||
Current year | -22.78% |
Managers | Title | Age | Since |
---|---|---|---|
Oludare Odumosu
CEO | Chief Executive Officer | - | 19-11-27 |
Rahul Ganesan
DFI | Director of Finance/CFO | - | - |
Greg Blake
BRD | Director/Board Member | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Osagie Imasogie
CHM | Chairman | 62 | 19-11-27 |
Timothy Slate
BRD | Director/Board Member | - | 16-10-19 |
Oludare Odumosu
CEO | Chief Executive Officer | - | 19-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.695 | +2.21% | 687 |
24-04-30 | 0.68 | -4.90% | 2,451 |
24-04-29 | 0.715 | +1.42% | 5,919 |
24-04-26 | 0.705 | -0.70% | 269 |
24-04-24 | 0.71 | +1.43% | 1,279 |
Delayed Quote Australian S.E., May 01, 2024 at 01:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.78% | 5.01M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- ZLD Stock